BlackRock Advisors’s Minerva Neurosciences NERV Stock Holding History

BlackRock Advisors’s Portfolio NERV Stock Details NERV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$113K	Sell	1,205 -59	-5%	-$6.02K	﹤0.01%	2988
2016 Q3	$143K	Buy	1,264 +415	+49%	+$40.3K	﹤0.01%	2853
2016 Q2	$69K	Buy	849 +613	+260%	+$39K	﹤0.01%	3128
2016 Q1	$12K	Hold	236	–	–	﹤0.01%	3549
2015 Q4	$11K	Hold	236	–	–	﹤0.01%	3615
2015 Q3	$10K	Hold	236	–	–	﹤0.01%	3655
2015 Q2	$11K	Buy	+236	New	+$10.1K	﹤0.01%	3604

Other funds holding NERV

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

HCMT

Highland Capital Management (Texas) Dallas, Texas $39M AUM

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock Advisors's NERV Position: Q4 2016 in Review

BlackRock Advisors reduced its Minerva Neurosciences (NERV) stake by 4.7% in Q4 2016, selling an estimated $6.02K and leaving 1,205 shares worth $113K. The position accounts for ﹤0.01% of the portfolio, ranked #2988.

BlackRock Advisors first reported a position in NERV in Q2 2015 and has held it in 7 quarters since. The position peaked at $143K in Q3 2016. 78 funds tracked by Wall St. Rank hold NERV as of Q4 2016.

BlackRock Advisors held 1,205 shares of Minerva Neurosciences worth $113K as of Q4 2016.
BlackRock Advisors sold 59 Minerva Neurosciences shares in Q4 2016, an estimated $6.02K.
Minerva Neurosciences made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2988 holding.
BlackRock Advisors first reported a position in Minerva Neurosciences in Q2 2015 and has held it in 7 quarters since.
BlackRock Advisors's Minerva Neurosciences position peaked at $143K in Q3 2016.
78 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.